Simulations Plus Stock
Price
Target price
-
-
-
-
-
?51.92
WKN: 924294 / Symbol: SLP / Name: Simulations Plus / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Simulations Plus Stock
Currently there is a rather positive sentiment for Simulations Plus with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 51 € shows a positive potential of 50.0% compared to the current price of 34.0 € for Simulations Plus.
Pros and Cons of Simulations Plus in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Simulations Plus vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Simulations Plus | - | - | - | - | - | - | - |
| MicroVision Inc | -0.770% | -7.859% | 13.253% | -69.248% | -58.685% | -91.823% | 72.065% |
| Fonar Corp. New | 1.880% | 8.667% | 16.429% | 5.844% | -7.910% | 12.414% | -16.109% |
| Allscripts Healthcare | -37.060% | -38.506% | -37.059% | -54.661% | -42.162% | -63.103% | -44.537% |
Comments
Simulations Plus, Inc. (NASDAQ: SLP) had its "buy" rating re-affirmed by analysts at Craig Hallum. They now have a $56.00 price target on the stock.
Show more
Ratings data for SLP provided by MarketBeat
Simulations Plus, Inc. (NASDAQ: SLP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Show more
Ratings data for SLP provided by MarketBeat
Simulations Plus, Inc. (NASDAQ: SLP) had its price target raised by analysts at Craig Hallum from $51.00 to $56.00. They now have a "buy" rating on the stock.
Show more
Ratings data for SLP provided by MarketBeat
News
Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the
Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the
Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the